These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38805016)

  • 1. Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals.
    Shukla A; Singh A; Tripathi S
    J Am Nutr Assoc; 2024; 43(7):614-626. PubMed ID: 38805016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets.
    Yapasert R; Khaw-On P; Banjerdpongchai R
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fatty Acid Lipid Metabolism Nexus in COVID-19.
    Tanner JE; Alfieri C
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33440724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication.
    Chu J; Xing C; Du Y; Duan T; Liu S; Zhang P; Cheng C; Henley J; Liu X; Qian C; Yin B; Wang HY; Wang RF
    Nat Metab; 2021 Nov; 3(11):1466-1475. PubMed ID: 34580494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor.
    Fonnesu R; Thunuguntla VBSC; Veeramachaneni GK; Bondili JS; La Rocca V; Filipponi C; Spezia PG; Sidoti M; Plicanti E; Quaranta P; Freer G; Pistello M; Mathai ML; Lai M
    Viruses; 2022 May; 14(5):. PubMed ID: 35632821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-185 Inhibits SARS-CoV-2 Infection through the Modulation of the Host's Lipid Microenvironment.
    Ahmed N; Francis ME; Ahmed N; Kelvin AA; Pezacki JP
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids.
    Tsai PH; Sun JR; Chien Y; Chan MS; Khor W; Yang HC; Huang CH; Hsiung CN; Hwa TY; Lin YY; Yeh CL; Wang ML; Yang YP; Chen YM; Tsai FT; Lee MS; Cheng YH; Tsai SK; Liu PC; Chou SJ; Chiou SH
    J Adv Res; 2024 Jun; 60():127-140. PubMed ID: 37557954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
    More SA; Patil AS; Sakle NS; Mokale SN
    Virology; 2021 Mar; 555():10-18. PubMed ID: 33421743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
    Lieber CM; Kang H-J; Sobolik EB; Sticher ZM; Ngo VL; Gewirtz AT; Kolykhalov AA; Natchus MG; Greninger AL; Suthar MS; Plemper RK
    J Virol; 2024 Sep; 98(9):e0090524. PubMed ID: 39207133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
    Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
    J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.
    Sturley SL; Rajakumar T; Hammond N; Higaki K; Márka Z; Márka S; Munkacsi AB
    J Lipid Res; 2020 Jul; 61(7):972-982. PubMed ID: 32457038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacerein: A potential multi-target therapeutic drug for COVID-19.
    de Oliveira PG; Termini L; Durigon EL; Lepique AP; Sposito AC; Boccardo E
    Med Hypotheses; 2020 Nov; 144():109920. PubMed ID: 32534337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based therapies against SARS-CoV-2 infection.
    Alketbi EH; Hamdy R; El-Kabalawy A; Juric V; Pignitter M; A Mosa K; Almehdi AM; El-Keblawy AA; Soliman SSM
    Rev Med Virol; 2021 Sep; 31(5):1-13. PubMed ID: 34546604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential inhibitors of SARS-CoV-2: recent advances.
    Jamalipour Soufi G; Iravani S
    J Drug Target; 2021 Apr; 29(4):349-364. PubMed ID: 33210953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Santopolo S; Riccio A; Santoro MG
    Biochem Biophys Res Commun; 2021 Jan; 538():80-87. PubMed ID: 33303190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication.
    Williams CG; Jureka AS; Silvas JA; Nicolini AM; Chvatal SA; Carlson-Stevermer J; Oki J; Holden K; Basler CF
    Cell Rep; 2021 Aug; 36(5):109479. PubMed ID: 34320401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.
    Proto MC; Fiore D; Piscopo C; Pagano C; Galgani M; Bruzzaniti S; Laezza C; Gazzerro P; Bifulco M
    Prog Lipid Res; 2021 Apr; 82():101099. PubMed ID: 33915202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.